Meru Sandbox

Skip to content

Meru Sandbox

Search

Search

Explore

Home

© Copyright 2024 Meru

Back to Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.

Muh-Hwa Yang

Contributions

Showing 1 - 8 out of 8

Author

Published January 1, 2014

Author

Published January 1, 2015

Author

Published July 1, 2014

Author

Published March 3, 2017

Author

Published August 1, 2015

Author

Published October 1, 2015

Author

Published September 1, 2015

Author

Published July 1, 2014